Back
Clinuvel Pharmaceuticals Quote, Financials, Valuation and Earnings
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
36
CLVLY
Clinuvel Pharmaceuticals
Last Price:
9.97
Seasonality Move:
2.81%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.Clinuvel Pharmaceuticals Price Quote
$9.97
+0.17 (+1.73%)
(Updated: May 1, 2024 at 6:55 PM ET)
Clinuvel Pharmaceuticals Key Stats
Sell
36
Clinuvel Pharmaceuticals (CLVLY)
is a Sell
Day range:
$9.97 - $9.97
52-week range:
$8.54 - $13.92
Dividend yield:
0.33%
P/E ratio:
24.65
P/S ratio:
9.65
P/B ratio:
4.04%
Volume:
2K
Avg. volume:
2.9K
1-year change:
-26.04%
Market cap:
$491.2M
Revenue:
$52.7M
EPS:
$0.38
How Much Does Clinuvel Pharmaceuticals Make?
-
How Much Are Clinuvel Pharmaceuticals's Sales Annually?
CLVLY Revenues are $52.7M -
How Much Profit Does Clinuvel Pharmaceuticals's Make A Year?
CLVLY net income is $20.6M
Is Clinuvel Pharmaceuticals Growing As A Company?
Data Unavailable
Clinuvel Pharmaceuticals Stock Price Performance
-
Did Clinuvel Pharmaceuticals Stock Go Up Last Month?
Clinuvel Pharmaceuticals share price went up by 3.59% last month -
Did CLVLY's Share Price Rise Over The Last Year?
CLVLY share price fell by -26.04% over the past 1 year
What Is Clinuvel Pharmaceuticals 52-Week High & Low?
-
What Is Clinuvel Pharmaceuticals’s 52-Week High Share Price?
Clinuvel Pharmaceuticals has traded as high as $13.92 over the past 52 weeks -
What Is Clinuvel Pharmaceuticals’s 52-Week Low Share Price?
Clinuvel Pharmaceuticals has traded as low as $8.54 over the past 52 weeks
Clinuvel Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Clinuvel Pharmaceuticals?
-
How Much Debt Does Clinuvel Pharmaceuticals Have?
Total long term debt quarterly is $728.2K -
How Much Cash Does Clinuvel Pharmaceuticals Have?
Cash and short term investments quarterly total is $118.9M -
What Is Clinuvel Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.43
Is Clinuvel Pharmaceuticals Cash Flow Positive?
Data Unavailable
Clinuvel Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CLVLY return on invested capital is 18.31% -
What Is Clinuvel Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 15.69% -
What Is CLVLY Return On Equity?
ROE is a measure of profitability and is 18.4%
Clinuvel Pharmaceuticals Earnings Date & Stock Price
-
What Is Clinuvel Pharmaceuticals's Stock Price Today?
A single share of CLVLY can be purchased today for 9.80 -
What Is Clinuvel Pharmaceuticals’s Stock Symbol?
Clinuvel Pharmaceuticals trades on the otcm under the ticker symbol: CLVLY -
When Is Clinuvel Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Clinuvel Pharmaceuticals is scheduled on May 2, 2024 -
When Is CLVLY's next ex-dividend date?
Clinuvel Pharmaceuticals's next ex-dividend date is September 7, 2023 -
How To Buy Clinuvel Pharmaceuticals Stock?
You can buy Clinuvel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Clinuvel Pharmaceuticals Competitors
-
Who Are Clinuvel Pharmaceuticals's Competitors?
Below is a list of companies who compete with Clinuvel Pharmaceuticals or are related in some way:
Clinuvel Pharmaceuticals Dividend Yield
-
What Is CLVLY Dividend Yield?
Clinuvel Pharmaceuticals’s dividend yield currently is 0.33% -
What Is Clinuvel Pharmaceuticals’s Payout Ratio?
Clinuvel Pharmaceuticals’s payout ratio is 8.06% -
When Did Clinuvel Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is May 2, 2024 -
What Is Clinuvel Pharmaceuticals’s Dividend Per Share?
Clinuvel Pharmaceuticals pays a dividend of $0.00 per share
Clinuvel Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable